Skip to main content
. Author manuscript; available in PMC: 2009 Sep 17.
Published in final edited form as: Neurogastroenterol Motil. 2008 Aug 5;21(2):149–159. doi: 10.1111/j.1365-2982.2008.01171.x

Table 3.

Clinical characteristics of Study 2 subjects with IBS-D

Description Controls IBS (n = 10) P-value (n = 10)
Age (years ± SEM) 33.9 ± 3.5 40 ± 2.3 ns
BMI (±SEM) 25.5 ± 1.7 28.6 ± 2.7 ns
Symptom severity IBS symptom severity (0–20 cm) 13.5 ± 1.5
    Abdominal pain Chronic abdominal pain (unpleasantness) 12.4 ± 0.8
Chronic abdominal pain (intensity) 14.1 ± 0.6
Current abdominal pain (unpleasantness) 11.7 ± 1.2
Current abdominal pain (intensity) 13.1 ± 1.1
Gynaecological history (n)
    Premenopausal phase Follicular 4 5 ns
Luteal 4 4
Menses 1 0
    Postmenopausal 1 1 ns
Chronic stress indicators [n (%)] Childhood abuse 1 (10) 2 (20) ns
Adult abuse 0 (0) 1 (10) ns
Early adverse event 0 (0) 1 (10) ns
HAD scores Anxiety 2.22 ± 0.43 5.2 ± 0.92 0.01
Depression 0.33 ± 0.24 3.7 ± 0.97 <0.01

BMI, body mass index. Chronic pain symptoms were rated over previous 1 month. Current pain was rated over previous 24 h. For premenopausal women not taking OCP, the menstrual cycle phase was determined by the count forward/backward method: menses, first 3 days of menses; follicular, days 4–14; luteal, day 14 onward and before menses.